Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Influenza vaccines are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza.
The European Center for Disease Prevention and Control recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five years of age, those with other health problems, and those who work in healthcare.
This report elaborates on the current development of the Influenza Vaccine industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Novavax
GlaxoSmithKline
Medicago
Moderna Therapeutics
UNM Pharma
CSL
Vaccitec
Altimmune
BionVax
Genentech
SK Chemicals
Green Cross
AstraZeneca
Sanofi
Shijiazhuang Yiling Pharmaceutical
Folia Biotech
FluGen
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Fluzone/Vaxigrip
FluMist
Fluarix and Flulaval
Anflu
Fluvax/Afluria
Flucelvax and Fluvirin
Application:
Adults
Pediatrics
Senior Citizens
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Influenza Vaccine Industry Overview
-
1.1.1 Influenza Vaccine Market Scope and Market Segments
-
1.1.2 Influenza Vaccine Industry Characteristics
-
1.1.3 Global and China Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Influenza Vaccine Production Value and Growth Rate (2017-2028)
-
1.2 Global Influenza Vaccine Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Fluzone/Vaxigrip
-
1.2.2 FluMist
-
1.2.3 Fluarix and Flulaval
-
1.2.4 Anflu
-
1.2.5 Fluvax/Afluria
-
1.2.6 Flucelvax and Fluvirin
-
1.3 Global Influenza Vaccine Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Adults
-
1.3.2 Pediatrics
-
1.3.3 Senior Citizens
-
1.4 Market Analysis by Region
-
1.4.1 North America Influenza Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Influenza Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Influenza Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Influenza Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Influenza Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Influenza Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Influenza Vaccine Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Influenza Vaccine Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Influenza Vaccine Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Influenza Vaccine Industry Porter's Five Forces Model Analysis
-
2.2.3 Influenza Vaccine Industry PEST Analysis
-
2.3 Influenza Vaccine Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Influenza Vaccine Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Influenza Vaccine Industry
Chapter 3 Global and China Influenza Vaccine Market, by Manufacturer
-
3.1 Global and China Influenza Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Influenza Vaccine Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Influenza Vaccine Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Influenza Vaccine Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Influenza Vaccine Market Top 3 Players
Chapter 4 Global and China Influenza Vaccine Market, by Type (2017-2028)
-
4.1 Influenza Vaccine Market Trend, by Type
-
4.2 Global Influenza Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Influenza Vaccine Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Influenza Vaccine Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Influenza Vaccine Price Trend, by Type (2017-2028)
-
4.3 China Influenza Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Influenza Vaccine Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Influenza Vaccine Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Influenza Vaccine Price Trend, by Type (2017-2028)
Chapter 5 Global and China Influenza Vaccine Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Influenza Vaccine Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Influenza Vaccine Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Influenza Vaccine Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Influenza Vaccine Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Influenza Vaccine Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Influenza Vaccine Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Influenza Vaccine Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Influenza Vaccine Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Influenza Vaccine Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Influenza Vaccine Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Influenza Vaccine Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Influenza Vaccine Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Influenza Vaccine Market Analysis
-
7.1 North America Influenza Vaccine Market, by Type
-
7.2 North America Influenza Vaccine Market, by Application
-
7.3 North America Influenza Vaccine Market Analysis and Forecast, by Country
-
7.3.1 United States Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Influenza Vaccine Market Analysis
-
8.1 Europe Influenza Vaccine Market, by Type
-
8.2 Europe Influenza Vaccine Market, by Application
-
8.3 Europe Influenza Vaccine Market Analysis and Forecast, by Country
-
8.3.1 Germany Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Influenza Vaccine Market Analysis
-
9.1 APAC Influenza Vaccine Market, by Type
-
9.2 APAC Influenza Vaccine Market, by Application
-
9.3 APAC Influenza Vaccine Market Analysis and Forecast, by Country
-
9.3.1 China Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Influenza Vaccine Market Analysis
-
10.1 Latin America, Middle East and Africa Influenza Vaccine Market, by Type
-
10.2 Latin America, Middle East and Africa Influenza Vaccine Market, by Application
-
10.3 Latin America, Middle East and Africa Influenza Vaccine Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Influenza Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Influenza Vaccine Company Profiles
-
11.1 Novavax
-
11.1.1 Novavax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Novavax Influenza Vaccine Product Profiles, Application and Specification
-
11.1.3 Novavax Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 GlaxoSmithKline
-
11.2.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 GlaxoSmithKline Influenza Vaccine Product Profiles, Application and Specification
-
11.2.3 GlaxoSmithKline Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Medicago
-
11.3.1 Medicago Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Medicago Influenza Vaccine Product Profiles, Application and Specification
-
11.3.3 Medicago Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Moderna Therapeutics
-
11.4.1 Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Moderna Therapeutics Influenza Vaccine Product Profiles, Application and Specification
-
11.4.3 Moderna Therapeutics Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 UNM Pharma
-
11.5.1 UNM Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 UNM Pharma Influenza Vaccine Product Profiles, Application and Specification
-
11.5.3 UNM Pharma Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 CSL
-
11.6.1 CSL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 CSL Influenza Vaccine Product Profiles, Application and Specification
-
11.6.3 CSL Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Vaccitec
-
11.7.1 Vaccitec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Vaccitec Influenza Vaccine Product Profiles, Application and Specification
-
11.7.3 Vaccitec Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Altimmune
-
11.8.1 Altimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Altimmune Influenza Vaccine Product Profiles, Application and Specification
-
11.8.3 Altimmune Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 BionVax
-
11.9.1 BionVax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 BionVax Influenza Vaccine Product Profiles, Application and Specification
-
11.9.3 BionVax Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Genentech
-
11.10.1 Genentech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Genentech Influenza Vaccine Product Profiles, Application and Specification
-
11.10.3 Genentech Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 SK Chemicals
-
11.11.1 SK Chemicals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 SK Chemicals Influenza Vaccine Product Profiles, Application and Specification
-
11.11.3 SK Chemicals Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Green Cross
-
11.12.1 Green Cross Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Green Cross Influenza Vaccine Product Profiles, Application and Specification
-
11.12.3 Green Cross Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 AstraZeneca
-
11.13.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 AstraZeneca Influenza Vaccine Product Profiles, Application and Specification
-
11.13.3 AstraZeneca Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Sanofi
-
11.14.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Sanofi Influenza Vaccine Product Profiles, Application and Specification
-
11.14.3 Sanofi Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 Shijiazhuang Yiling Pharmaceutical
-
11.15.1 Shijiazhuang Yiling Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccine Product Profiles, Application and Specification
-
11.15.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Folia Biotech
-
11.16.1 Folia Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Folia Biotech Influenza Vaccine Product Profiles, Application and Specification
-
11.16.3 Folia Biotech Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 FluGen
-
11.17.1 FluGen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 FluGen Influenza Vaccine Product Profiles, Application and Specification
-
11.17.3 FluGen Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Influenza Vaccine Industry Investment Prospect and Risk Assessment
-
12.1 Influenza Vaccine Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Influenza Vaccine Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure China Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Global Influenza Vaccine Production Value and Growth Rate (2017-2028)
-
Figure China Influenza Vaccine Production Value and Growth Rate (2017-2028)
-
Figure Global Influenza Vaccine Market Size and Growth Rate of Fluzone/Vaxigrip (2017-2028)
-
Figure Global Influenza Vaccine Market Size and Growth Rate of FluMist (2017-2028)
-
Figure Global Influenza Vaccine Market Size and Growth Rate of Fluarix and Flulaval (2017-2028)
-
Figure Global Influenza Vaccine Market Size and Growth Rate of Anflu (2017-2028)
-
Figure Global Influenza Vaccine Market Size and Growth Rate of Fluvax/Afluria (2017-2028)
-
Figure Global Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin (2017-2028)
-
Figure Global Influenza Vaccine Market Size and Growth Rate of Adults (2017-2028)
-
Figure Global Influenza Vaccine Market Size and Growth Rate of Pediatrics (2017-2028)
-
Figure Global Influenza Vaccine Market Size and Growth Rate of Senior Citizens (2017-2028)
-
Figure North America Influenza Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Influenza Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Influenza Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Influenza Vaccine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Influenza Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Influenza Vaccine Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Influenza Vaccine Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Influenza Vaccine Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Influenza Vaccine Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Influenza Vaccine Market Share, by Manufacturer in 2021
-
Figure Global and China Influenza Vaccine Market Share, by Manufacturer in 2022
-
Table Global Influenza Vaccine Sales Volume, by Type (2017-2028)
-
Table Global Influenza Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure Global Influenza Vaccine Sales Volume Share, by Type (2017-2028)
-
Table Global Influenza Vaccine Sales Value, by Type (2017-2028)
-
Table Global Influenza Vaccine Sales Value Share, by Type (2017-2028)
-
Figure Global Influenza Vaccine Price Trend, by Type (2017-2028)
-
Table China Influenza Vaccine Sales Volume, by Type (2017-2028)
-
Table China Influenza Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure China Influenza Vaccine Sales Volume Share, by Type (2017-2028)
-
Table China Influenza Vaccine Sales Value, by Type (2017-2028)
-
Table China Influenza Vaccine Sales Value Share, by Type (2017-2028)
-
Figure China Influenza Vaccine Price Trend, by Type (2017-2028)
-
Table Global Influenza Vaccine Sales Volume, by Application (2017-2028)
-
Table Global Influenza Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure Global Influenza Vaccine Sales Volume Share, by Application (2017-2028)
-
Table Global Influenza Vaccine Sales Value, by Application (2017-2028)
-
Table Global Influenza Vaccine Sales Value Share, by Application (2017-2028)
-
Figure Global Influenza Vaccine Sales Value Share, by Application (2017-2028)
-
Table China Influenza Vaccine Sales Volume, by Application (2017-2028)
-
Table China Influenza Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure China Influenza Vaccine Sales Volume Share, by Application (2017-2028)
-
Table China Influenza Vaccine Sales Value, by Application (2017-2028)
-
Table China Influenza Vaccine Sales Value Share, by Application (2017-2028)
-
Figure China Influenza Vaccine Sales Value Share, by Application (2017-2028)
-
Figure China Influenza Vaccine Production, Import, Consumption and Export (2017-2022)
-
Figure North America Influenza Vaccine Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Influenza Vaccine Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Influenza Vaccine Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Influenza Vaccine Production, Import, Consumption and Export (2017-2022)
-
Table North America Influenza Vaccine Sales Volume, by Type (2017-2028)
-
Table North America Influenza Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure North America Influenza Vaccine Sales Volume Share, by Type (2017-2028)
-
Table North America Influenza Vaccine Sales Volume, by Application (2017-2028)
-
Table North America Influenza Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure North America Influenza Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure United States Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure United States Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Canada Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Table Europe Influenza Vaccine Sales Volume, by Type (2017-2028)
-
Table Europe Influenza Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure Europe Influenza Vaccine Sales Volume Share, by Type (2017-2028)
-
Table Europe Influenza Vaccine Sales Volume, by Application (2017-2028)
-
Table Europe Influenza Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure Europe Influenza Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure Germany Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure UK Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure UK Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure France Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure France Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Italy Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Spain Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Poland Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Russia Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Table APAC Influenza Vaccine Sales Volume, by Type (2017-2028)
-
Table APAC Influenza Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure APAC Influenza Vaccine Sales Volume Share, by Type (2017-2028)
-
Table APAC Influenza Vaccine Sales Volume, by Application (2017-2028)
-
Table APAC Influenza Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure APAC Influenza Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure China Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure China Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Japan Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure India Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure India Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Influenza Vaccine Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Influenza Vaccine Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Influenza Vaccine Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Influenza Vaccine Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Influenza Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Influenza Vaccine Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Influenza Vaccine Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Influenza Vaccine Sales Value and Growth Rate (2017-2028)
-
Table Novavax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novavax Product Profiles, Application and Specification
-
Table Novavax Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GlaxoSmithKline Product Profiles, Application and Specification
-
Table GlaxoSmithKline Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Medicago Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Medicago Product Profiles, Application and Specification
-
Table Medicago Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Moderna Therapeutics Product Profiles, Application and Specification
-
Table Moderna Therapeutics Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table UNM Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table UNM Pharma Product Profiles, Application and Specification
-
Table UNM Pharma Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CSL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CSL Product Profiles, Application and Specification
-
Table CSL Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Vaccitec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Vaccitec Product Profiles, Application and Specification
-
Table Vaccitec Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Altimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Altimmune Product Profiles, Application and Specification
-
Table Altimmune Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BionVax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BionVax Product Profiles, Application and Specification
-
Table BionVax Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Genentech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Genentech Product Profiles, Application and Specification
-
Table Genentech Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table SK Chemicals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table SK Chemicals Product Profiles, Application and Specification
-
Table SK Chemicals Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Green Cross Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Green Cross Product Profiles, Application and Specification
-
Table Green Cross Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Product Profiles, Application and Specification
-
Table AstraZeneca Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shijiazhuang Yiling Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shijiazhuang Yiling Pharmaceutical Product Profiles, Application and Specification
-
Table Shijiazhuang Yiling Pharmaceutical Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Folia Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Folia Biotech Product Profiles, Application and Specification
-
Table Folia Biotech Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table FluGen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table FluGen Product Profiles, Application and Specification
-
Table FluGen Influenza Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
